Commentary: Thyroid eye disease-does the profile differ in India?
作者信息
Grover Ashok Kumar
机构信息
Department of Ophthalmology, Sir Ganga Ram Hospital and Vision Eye Centres, New Delhi, India.
出版信息
Indian J Ophthalmol. 2020 Aug;68(8):1635. doi: 10.4103/ijo.IJO_2274_20.
Abstract
摘要
相似文献
1
Commentary: Thyroid eye disease-does the profile differ in India?
Indian J Ophthalmol. 2020 Aug;68(8):1635. doi: 10.4103/ijo.IJO_2274_20.
2
Commentary: Thyroid eye disease in India: A wake-up call?评论：印度的甲状腺眼病：一个警钟？
Indian J Ophthalmol. 2020 Aug;68(8):1614-1615. doi: 10.4103/ijo.IJO_546_20.
3
Clinical assessment of patients with thyroid eye disease.甲状腺眼病患者的临床评估
Br J Hosp Med (Lond). 2016 Jan;77(1):C2-5. doi: 10.12968/hmed.2016.77.1.C2.
4
Commentary: Risk factors predicting visual morbidity in thyroid eye disease.评论：预测甲状腺眼病视力损害的危险因素。
Indian J Ophthalmol. 2020 Aug;68(8):1627-1628. doi: 10.4103/ijo.IJO_1851_20.
5
Thyroid eye disease for the primary care physician.基层医疗医生眼中的甲状腺眼病
Dis Mon. 2014 Jun;60(6):292-8. doi: 10.1016/j.disamonth.2014.03.010.
6
The relationship between thyroid eye disease and radioiodine treatment.甲状腺眼病与放射性碘治疗之间的关系。
Nucl Med Commun. 2019 Mar;40(3):194-198. doi: 10.1097/MNM.0000000000000965.
7
GRAVES OPHTHALMOPATHY--TERAPEUTICAL ALTERNATIVES.格雷夫斯眼病——治疗选择
Rom J Ophthalmol. 2015 Apr-Jun;59(2):103-6.
8
Graves' Ophthalmopathy in a Paediatric Population.儿童人群中的格雷夫斯眼病
Klin Monbl Augenheilkd. 2017 Apr;234(4):591-594. doi: 10.1055/s-0043-100566. Epub 2017 Mar 22.
9
Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.病毒性结膜炎干扰甲状腺眼病的临床活动评分及治疗。
Orbit. 2006 Mar;25(1):27-9. doi: 10.1080/01676830500505871.
10
Clinical evaluation of Graves ophthalmopathy in north-east Islamic Republic of Iran.伊朗伊斯兰共和国东北部格雷夫斯眼病的临床评估
East Mediterr Health J. 2008 Jul-Aug;14(4):841-9.
引用本文的文献
1
Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.甲状腺眼病最新进展：患病率、诊断和治疗的地域差异。
Indian J Ophthalmol. 2022 Jul;70(7):2335-2345. doi: 10.4103/ijo.IJO_3217_21.
本文引用的文献
1
Clinical profile of thyroid eye disease and factors predictive of disease severity.甲状腺眼病的临床特征及疾病严重程度的预测因素。
Indian J Ophthalmol. 2020 Aug;68(8):1629-1634. doi: 10.4103/ijo.IJO_104_20.
2
Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.威胁视力的格雷夫斯眼病：多学科甲状腺眼病门诊 20 年的经验。
Clin Endocrinol (Oxf). 2019 Jan;90(1):208-213. doi: 10.1111/cen.13880. Epub 2018 Nov 19.
3
Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.354例中国患者中重度甲状腺相关性眼病的临床特征
PLoS One. 2017 May 4;12(5):e0176064. doi: 10.1371/journal.pone.0176064. eCollection 2017.
4
PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.PREGO（格雷夫斯眼眶病表现）研究：2000年至2012年期间转诊至欧洲格雷夫斯眼眶病研究组（EUGOGO）中心的模式变化。
Br J Ophthalmol. 2015 Nov;99(11):1531-5. doi: 10.1136/bjophthalmol-2015-306733. Epub 2015 May 7.
5
Thyroid eye disease: a Southeast Asian experience.甲状腺眼病：东南亚地区的经验
Br J Ophthalmol. 2015 Apr;99(4):512-8. doi: 10.1136/bjophthalmol-2014-305649. Epub 2014 Oct 31.
6
Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India.在印度北部一家转诊中心就诊的格雷夫斯病患者中格雷夫斯眼病的患病率。
Indian J Med Res. 2014 Jan;139(1):99-104.
7
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.格雷夫斯眼眶病患者特征及治疗策略的多中心研究：欧洲格雷夫斯眼眶病研究组的首次经验
Eur J Endocrinol. 2003 May;148(5):491-5. doi: 10.1530/eje.0.1480491.
Zotero 插件